U.S. Markets closed

Compugen Ltd. (CGEN)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
3.15-0.10 (-3.08%)
At close: 4:00PM EDT
People also watch
Full screen
Previous Close3.25
Bid3.00 x 200
Ask3.60 x 1800
Day's Range3.03 - 3.25
52 Week Range3.03 - 7.57
Avg. Volume130,910
Market Cap161.07M
PE Ratio (TTM)-5.08
EPS (TTM)-0.62
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.50
Trade prices are not sourced from all markets
  • PR Newswire12 days ago

    Compugen to Present at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference Next Month

    Compugen Ltd. (CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, announced today that CGEN-15032, a newly-disclosed novel myeloid and epithelial immuno-oncology target, will be the subject of both an oral and a poster presentation at the 3rd annual CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference taking place September 6-9, 2017 in Mainz/Frankfurt, Germany. The presentation titled "Computational discovery and experimental validation of CGEN-15032 as a novel target for cancer immunotherapy" is scheduled as part of the session titled "Other checkpoint blocking and immunomodulating antibodies," on Friday, September 8, 2:00-3:45 pm CEST.

  • ACCESSWIRE15 days ago

    Corporate News Blog - Paul Sekhri Appointed Chairman of Board at Drug Discovery Company Compugen

    Research Desk Line-up: Seattle Genetics Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 4, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for ...

  • Associated Press17 days ago

    Compugen reports 2Q loss

    The Holon, Israel-based company said it had a loss of 18 cents per share. The company's shares closed at $3.80. A year ago, they were trading at $6.91. _____ This story was generated by Automated Insights ...